Moreover, the expression of SLC16A4 was closely associated with the clinical pathological features of lung cancer patients, including gender, tumor invasion depth, lymph node metastasis, tumor stage, and smoking history. This evidence concerns the gene SLC16A4 and lung carcinoma.